These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 25461253)

  • 1. C-X-C motif chemokine 12 influences the development of extramedullary hematopoiesis in the spleens of myelofibrosis patients.
    Wang X; Cho SY; Hu CS; Chen D; Roboz J; Hoffman R
    Exp Hematol; 2015 Feb; 43(2):100-9.e1. PubMed ID: 25461253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spleens of myelofibrosis patients contain malignant hematopoietic stem cells.
    Wang X; Prakash S; Lu M; Tripodi J; Ye F; Najfeld V; Li Y; Schwartz M; Weinberg R; Roda P; Orazi A; Hoffman R
    J Clin Invest; 2012 Nov; 122(11):3888-99. PubMed ID: 23023702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding Splenomegaly in Myelofibrosis: Association with Molecular Pathogenesis.
    Song MK; Park BB; Uhm JE
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of CXCL12 processing on CD34+ cell migration in myeloproliferative neoplasms.
    Cho SY; Xu M; Roboz J; Lu M; Mascarenhas J; Hoffman R
    Cancer Res; 2010 Apr; 70(8):3402-10. PubMed ID: 20388788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of hematopoietic stem cell transplant on splenic extramedullary hematopoiesis in patients with myeloproliferative neoplasm-associated myelofibrosis.
    Pizzi M; Gergis U; Chaviano F; Orazi A
    Hematol Oncol Stem Cell Ther; 2016 Sep; 9(3):96-104. PubMed ID: 27521149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential treatment of CD34+ cells from patients with primary myelofibrosis with chromatin-modifying agents eliminate JAK2V617F-positive NOD/SCID marrow repopulating cells.
    Wang X; Zhang W; Tripodi J; Lu M; Xu M; Najfeld V; Li Y; Hoffman R
    Blood; 2010 Dec; 116(26):5972-82. PubMed ID: 20858855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S1P(1) overexpression stimulates S1P-dependent chemotaxis of human CD34+ hematopoietic progenitor cells but strongly inhibits SDF-1/CXCR4-dependent migration and in vivo homing.
    Ryser MF; Ugarte F; Lehmann R; Bornhäuser M; Brenner S
    Mol Immunol; 2008 Nov; 46(1):166-71. PubMed ID: 18760838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel findings of splenic extramedullary hematopoiesis during primary myelofibrosis, post-essential thrombocythemia, and post-polycythemia vera myelofibrosis.
    Guy A; Bidet A; Ling C; Caumont C; Boureau L; Viallard JF; Parrens M
    Virchows Arch; 2021 Oct; 479(4):755-764. PubMed ID: 33934231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A thrombopoietin receptor antagonist is capable of depleting myelofibrosis hematopoietic stem and progenitor cells.
    Wang X; Haylock D; Hu CS; Kowalczyk W; Jiang T; Qiu J; Mosoyan G; He W; Marshall N; Mascarenhas J; Tarasova A; Brody J; Winkler D; Hoffman R
    Blood; 2016 Jun; 127(26):3398-409. PubMed ID: 27114459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hmga2 promotes the development of myelofibrosis in Jak2
    Dutta A; Hutchison RE; Mohi G
    Blood; 2017 Aug; 130(7):920-932. PubMed ID: 28637665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JAK2 inhibitors do not affect stem cells present in the spleens of patients with myelofibrosis.
    Wang X; Ye F; Tripodi J; Hu CS; Qiu J; Najfeld V; Novak J; Li Y; Rampal R; Hoffman R
    Blood; 2014 Nov; 124(19):2987-95. PubMed ID: 25193869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary myelofibrosis marrow-derived CD14+/CD34- monocytes induce myelofibrosis-like phenotype in immunodeficient mice and give rise to megakaryocytes.
    Manshouri T; Verstovsek S; Harris DM; Veletic I; Zhang X; Post SM; Bueso-Ramos CE; Estrov Z
    PLoS One; 2019; 14(9):e0222912. PubMed ID: 31569199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction of the abnormal trafficking of primary myelofibrosis CD34+ cells by treatment with chromatin-modifying agents.
    Wang X; Zhang W; Ishii T; Sozer S; Wang J; Xu M; Hoffman R
    Cancer Res; 2009 Oct; 69(19):7612-8. PubMed ID: 19752087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P-Selectin Sustains Extramedullary Hematopoiesis in the Gata1 low Model of Myelofibrosis.
    Spangrude GJ; Lewandowski D; Martelli F; Marra M; Zingariello M; Sancillo L; Rana RA; Migliaccio AR
    Stem Cells; 2016 Jan; 34(1):67-82. PubMed ID: 26439305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hematopoietic reconstitution of fresh and cultured cord blood CD34+ cells in NOD/SCID mice].
    Yang S; Cai HB; Jin HL; Tan WS
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Oct; 24(10):947-9. PubMed ID: 18845075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells.
    Hogan CJ; Shpall EJ; McNiece I; Keller G
    Biol Blood Marrow Transplant; 1997 Nov; 3(5):236-46. PubMed ID: 9450918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The spleen of patients with myelofibrosis harbors defective mesenchymal stromal cells.
    Avanzini MA; Abbonante V; Catarsi P; Dambruoso I; Mantelli M; Poletto V; Lenta E; Guglielmelli P; Croce S; Cobianchi L; Jemos B; Campanelli R; Bonetti E; Di Buduo CA; Salmoiraghi S; Villani L; Massa M; Boni M; Zappatore R; Iurlo A; Rambaldi A; Vannucchi AM; Bernasconi P; Balduini A; Barosi G; Rosti V;
    Am J Hematol; 2018 May; 93(5):615-622. PubMed ID: 29359451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imetelstat, a telomerase inhibitor, is capable of depleting myelofibrosis stem and progenitor cells.
    Wang X; Hu CS; Petersen B; Qiu J; Ye F; Houldsworth J; Eng K; Huang F; Hoffman R
    Blood Adv; 2018 Sep; 2(18):2378-2388. PubMed ID: 30242099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulated expression of CXCL12 in human spleens with extramedullary haematopoiesis.
    Miwa Y; Hayashi T; Suzuki S; Abe S; Onishi I; Kirimura S; Kitagawa M; Kurata M
    Pathology; 2013 Jun; 45(4):408-16. PubMed ID: 23619587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the TGF-β1 signaling abnormalities in the Gata1low mouse model of myelofibrosis.
    Zingariello M; Martelli F; Ciaffoni F; Masiello F; Ghinassi B; D'Amore E; Massa M; Barosi G; Sancillo L; Li X; Goldberg JD; Rana RA; Migliaccio AR
    Blood; 2013 Apr; 121(17):3345-63. PubMed ID: 23462118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.